Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000750a IKBKE
Assay data:1 Tested
SummaryRelated BioAssays by Target
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000701a IKBKE
Affinity Biochemical interaction (TR-FRET-based kinase activity inhibition assay (1 M ATP)) EUB0000701a IKBKE
Assay data:1 Active, 1 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
Affinity Biochemical interaction (TR-FRET-based kinase activity inhibition assay (1 M ATP)) EUB0000305b IKBKE
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Affinity On-target Cellular interaction (NanoBRET assay (HEK293T cells)) EUB0000701a IKBKE
Affinity On-target Cellular interaction (NanoBRET assay (HEK293T cells)) EUB0000305b IKBKE
Affinity Phenotypic Cellular interaction (pIRF3 cell-based mechanistic assay in MDA-MB231 cells) EUB0000305b IKBKE
Inhibition of human full length recombinant IKKepsilon assessed as residual activity at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma 33P]-ATP by radiometric scintillation counting assay relative to control
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of IKK epsilon (unknown origin)
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
IKK-epsilon DiscoveRx kinase panel
IKKepsilon(h) Kinase panel
Inhibition of IKKepsilon (unknown origin) at 1 uM
Inhibition of full length recombinant human IKKepsilon using casein as substrate incubated for 40 mins in presence of [gamma-33P-ATP] by radiometric scintillation assay
Assay data:4 Active, 2 Activity ≤ 1 µM, 4 Tested
IKKe Biochemical Assay from US Patent US11440899: "Pyrimidine TBK/IKKe inhibitor compounds and uses thereof"
Assay data:98 Active, 95 Activity ≤ 1 µM, 98 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Caliper Kinase Assay from US Patent US10676460: "Quinazolines as potassium ion channel inhibitors"
Assay data:1 Active, 1 Activity ≤ 1 µM, 3 Tested
Time-Resolved Fluorescence-based Lanthascreen Assay from US Patent US9433622: "Pyrimidine compounds useful in the treatment of diseases mediated by IKKE and/or TBK1 mechanisms"
Assay data:165 Active, 165 Activity ≤ 1 µM, 165 Tested
IKKepsilon Flashplate Assay from US Patent US9273029: "Pyridine-and pyrazine derivatives"
Assay data:51 Active, 33 Activity ≤ 1 µM, 51 Tested
IKKε Kinase Assay from US Patent US9249114: "Thiazole derivatives"
Assay data:27 Active, 19 Activity ≤ 1 µM, 27 Tested
Time-Resolved Fluorescence-based Lanthascreen Assay from US Patent US8962609: "Pyrimidine compounds as inhibitors of protein kinases IKK epsilon and/or TBK-1, processes for their preparation, and pharmaceutical compositions containing them"
Assay data:72 Active, 61 Activity ≤ 1 µM, 72 Tested
Flashplate Assay from US Patent US8969335: "Benzonitrile derivatives as kinase inhibitors"
Assay data:95 Active, 1 Activity ≤ 1 nM, 93 Activity ≤ 1 µM, 95 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on